Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia

Published:2018-10-25 Issue:6 Volume:52 Page:1801482
ISSN:0903-1936
Container-title:European Respiratory Journal
language:en
Short-container-title:Eur Respir J

Author:

Rotenberg Cécile,Besnard Valérie,Brillet Pierre-Yves,Giraudier Stéphane,Nunes Hilario,Valeyre Dominique

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference18 articles.

1. Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force;Baughman;Sarcoidosis Vasc Diffuse Lung Dis,2011

2. Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis: Cohort study of a 40-year clinical experience at a tertiary referral center in Barcelona, Spain;Mañá;Medicine,2017

3. Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms

4. JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease

5. JAK2 activation by growth hormone and other cytokines

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recruitment of CXCR4+ type 1 innate lymphoid cells distinguishes sarcoidosis from other skin granulomatous diseases;Journal of Clinical Investigation;2024-09-03

2. The immunopathogenesis of sarcoidosis;Journal of Autoimmunity;2024-05

3. Complete response to mTOR inhibitor following JAKi failure in severe pulmonary sarcoidosis;Pulmonology;2024-04

4. Advance in pathogenesis of sarcoidosis: Triggers and progression;Heliyon;2024-03

5. Biomarkers in Sarcoidosis;Clinics in Chest Medicine;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3